Low Testosterone (Male Hypogonadism) | Cleveland Clinic
Posted: October 9, 2018 at 11:41 pm
What is low testosterone (male hypogonadism)?
Low testosterone (male hypogonadism) is a condition in which the testes (testicles, the male reproductive glands) do not produce enough testosterone (a male sex hormone).
In men, testosterone helps maintain and develop:
Low testosterone affects almost 40% of men aged 45 and older. It is difficult to define normal testosterone levels, because levels vary throughout the day and are affected by body mass index (BMI), nutrition, alcohol consumption, certain medications, age and illness.
As a man ages, the amount of testosterone in his body gradually drops. This natural decline starts after age 30 and continues (about 1% per year) throughout his life.
There are many other potential causes of low testosterone, including the following:
Symptoms of low testosterone depend on the age of person, and include the following:
Other changes that occur with low testosterone include:
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Go here to see the original:
Low Testosterone (Male Hypogonadism) | Cleveland Clinic
- Male Hypogonadism - Causes, Symptoms, Diagnosis, Treatment - January 2nd, 2019
- Male Hypogonadism | Endocrinology | Dartmouth-Hitchcock - November 7th, 2018
- Hypogonadism? | Go Ask Alice! - October 9th, 2018
- Endo Pharmaceuticals | Hypogonadism - August 10th, 2018
- Hypogonadism disease: Malacards - Research Articles, Drugs ... - July 25th, 2018
- Male hypogonadism - You and Your Hormones - July 11th, 2018
- Hypogonadism (Low Testosterone) | Men's Health Resource Center - June 28th, 2018
- Late-onset hypogonadism - Wikipedia - April 1st, 2018
- Hypogonadism Treatment & Management: Approach Considerations ... - March 5th, 2018
- Hypogonadism: Practice Essentials, Background, Pathophysiology - February 13th, 2018
- Hypogonadism - UCSF Medical Center - February 4th, 2018
- Diminished Androgen and Estrogen Receptors and Aromatase ... - January 20th, 2018
- Healthier Andropause Build to Balance - January 20th, 2018
- Attention, Men: Doing This Every Day Could Lower Your ... - January 20th, 2018
- Lilly pulls Axiron from Korean market | Righting Injustice - January 20th, 2018
- Hypogonadism | Cleveland Clinic - December 30th, 2017
- Primary Hypogonadism VS Secondary Hypogonadism ... - December 29th, 2017
- Hypogonadism | Children's Hospital of Philadelphia - December 19th, 2017
- Male hypogonadism - Diagnosis and treatment - Mayo Clinic - December 17th, 2017
- Hypogonadism Causes & Information | Cleveland Clinic - December 12th, 2017
- Low Testosterone | Hormone Health Network - November 24th, 2017
- Induction of fertility in men with secondary hypogonadism - November 4th, 2017
- Hypogonadism, Male | ARUPConsult Lab Test Selection - October 19th, 2017
- Hypogonadism Testosterone Therapy Treatment | Ageonics Medical - October 19th, 2017
- Hypogonadism: Types, Causes, & Symptoms - healthline.com - October 13th, 2017
- Male Hypogonadism Drug Market Analysis, Share and Size, Trends, Industry Growth And Segment Forecasts To 2021 - satPRnews (press release) - September 6th, 2017
- Asia-Pacific Male Hypogonadism Market by Region, Production, Consumption, Revenue, Market Share and Growth ... - satPRnews (press release) - September 6th, 2017
- Male hypogonadism - Treatment - Mayo Clinic - August 30th, 2017
- Wives of 3 of 4 patients treated for hypogonadism conceive - Times of India - August 22nd, 2017
- Pipeline Landscape of Male Hypogonadism Covering Therapeutic Assessment and Drug Portfolio in 2017 - Digital Journal - August 17th, 2017
- Long-term testosterone therapy improves urinary, sexual function and quality of life - Medical Xpress - August 15th, 2017
- Male Hypogonadism Sales Market Research Report 2017 to 2022 - The Donohue Report - August 12th, 2017
- Lipocine resubmits NDA for LPCN 1021 in hypogonadism - The Pharma Letter (registration) - August 12th, 2017
- 3 Things In Biotech You Should Learn Today: August 12, 2017 - Seeking Alpha - August 12th, 2017
- Male Hypogonadism Market Growth Forecast Analysis by ... - Green Mountain Outlook - August 12th, 2017
- Global Male Hypogonadism Market 2017 Allergan Plc., Endo International Plc., Ferring, AbbVie Inc. - DailyCommerceNews - August 10th, 2017
- Here's What Lipocine Inc. (NASDAQ:LPCN)'s Latest Announcement Means For Shareholders - Market Exclusive - August 10th, 2017
- Lipocine (LPCN) Resubmits NDA for Oral Testosterone Product Candidate, LPCN 1021, for Treatment of Hypogonadism - StreetInsider.com - August 9th, 2017
- Global Male Hypogonadism Market 2017- Astrazeneca Plc., Merck & Co. Inc., Laboratories Genevrier, Allergan Plc. - DailyCommerceNews - August 8th, 2017
- Male Hypogonadism Market Research Report 2017 To 2022 - Equity Insider (press release) - August 4th, 2017
- Male Hypogonadism Market Set for Expansive Growth over Next 10 Years - Digital Journal - August 3rd, 2017
- Research details developments in the male hypogonadism - market ... - WhaTech - August 2nd, 2017
- Male Hypogonadism Pipeline Report, H1 2017 - Therapeutics Review of 15 Companies & Drug Profiles - Research ... - Business Wire (press release) - July 11th, 2017
- Man, 34, 'DOUBLES the size of his penis in nine months thanks to hormone injections' - The Sun - June 29th, 2017
- Man Doubles Penis Size After Testosterone Injections To Treat Hypogonadism Condition - Medical Daily - June 29th, 2017
- Male Hypogonadism Market predicts rise in demand by 2016-2024 - People Today 24 - June 23rd, 2017
- Lipocine (LPCN) Spikes On Testosterone Dosing Data - Economic Calendar - June 21st, 2017
- Nasal Testosterone Gel Shown to Normalize Androgen Levels, Improve Erectile Function & Mood in Hypogonadal Men - UroToday - June 21st, 2017
- Hormone Treatments Helps Man's Penis DOUBLE In Size - YourTango - June 20th, 2017
- Assessment of Hypogonadism in Men With Type 2 Diabetes: A Cross-Sectional Study From Saudi Arabia. - UroToday - June 19th, 2017
- Low Testosterone Treatments | Houston TX - June 18th, 2017
- Testosterone Support Still Going Strong in Men's Supplements ... - Nutritional Outlook - June 18th, 2017
- Acerus Announces Licensing of NATESTO - Business Wire (press release) - June 14th, 2017
- Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in ... - UroToday - June 14th, 2017
- Long-Term Testosterone Tx Assessed in Men With Hypogonadism and T2D - Monthly Prescribing Reference (registration) - June 13th, 2017
- Virtual graphic card for games 3d analyzer - Top rated online casinos for us players - Online live casino deutschland - Microfinance Monitor - June 13th, 2017
- Acerus Announces NATESTO License Agreement with Therios ... - Business Wire (press release) - June 11th, 2017
- Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes - Endocrinology Advisor - June 11th, 2017
- ASCO 2017: Prostate cancer in 696 hypogonadal men with and without long-term testosterone therapy: Results from a ... - UroToday - June 9th, 2017
- Low testosterone risk flagged for testicular cancer survivors - medwireNews - June 9th, 2017
- Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the ... - UroToday - May 31st, 2017
- External Beam Radiotherapy Affects Serum Testosterone in Patients ... - UroToday - May 31st, 2017
- The Ball's In Your Court - Lexology (registration) - May 25th, 2017
- Hypogonadism Hormone Health Network - May 23rd, 2017
- AUA 2017: Calculated Free T and T:E Ratio but not Total Testosterone and Estradiol Predict Low Libido - UroToday - May 21st, 2017
- AUA 2017: Prevalence of Hormonal Abnormalities in Young Men with Erectile Dysfunction - UroToday - May 21st, 2017
- Hypogonadism Treatment & Management: Approach ... - May 20th, 2017
- AUA 2017: The Effect of Shift Work on a Man's Sexual and Urologic Health - UroToday - May 19th, 2017
- The Effect of Shift Work on a Man's Sexual and Urologic Health - PR Newswire (press release) - May 13th, 2017
- Adherence to Topical Testosterone Therapy in Primary and Secondary Hypogonadism - Endocrinology Advisor - May 12th, 2017
- AYTU BIOSCIENCE, INC. (OTCMKTS:AYTU) Files An 8-K Results of Operations and Financial Condition - Market Exclusive - May 12th, 2017
- 19 foods that lower testosterone levels - Bel Marra Health - May 12th, 2017
- AYTU BIOSCIENCE, INC. (OTCMKTS:AYTU) Files An 8-K Entry into a Material Definitive Agreement - Market Exclusive - May 10th, 2017
- In Hypogonadism, Stroke May Be Prevented With Testosterone Replacement Therapy - Neurology Advisor - May 9th, 2017
- What's in the Cards for Repros (RPRX) this Earnings Season? - Zacks.com - May 5th, 2017
- Testosterone Replacement Therapy May Protect Against Stroke, Heart Attack in Hypogonadism - Endocrinology Advisor - May 5th, 2017
- Aytu BioScience to Provide Fiscal Third Quarter 2017 Business Update - PR Newswire (press release) - May 3rd, 2017
- Global Male Hypogonadism Market, 20162024: Type. Size, Share, Trends & Forecast Report - satPRnews (press release) - April 27th, 2017
- Global Male Hypogonadism Market, 20162024: Type. Size, Share, Trends & Forecast Report - MilTech - April 26th, 2017
- Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms ... - UroToday - April 25th, 2017